Effective and safe treatment of a novel IL2RA deficiency with rapamycin
N Lai, L Liu, L Lin, C Cui, Y Wang… - The journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Effective and safe treatment of a novel IL2RA deficiency with rapamycin Effective and safe
treatment of a novel IL2RA deficiency with rapamycin J Allergy Clin Immunol Pract. 2020
Mar;8(3):1132-1135.e4. doi: 10.1016/j.jaip.2019.09.027. Epub 2019 Oct 9. Authors Nannan Lai
1 , Luyao Liu 2 , Li Lin 2 , Chaoqun Cui 1 , Ying Wang 2 , Qing Min 1 , Ermeng Xiong 1 , Wenjie
Wang 2 , Wenjing Ying 2 , Qinhua Zhou 2 , Jia Hou 2 , Jinqiao Sun 3 , Ji-Yang Wang 4 ,
Xiaochuan Wang 5 Affiliations 1 Department of Immunology, School of Basic Medical Sciences …
treatment of a novel IL2RA deficiency with rapamycin J Allergy Clin Immunol Pract. 2020
Mar;8(3):1132-1135.e4. doi: 10.1016/j.jaip.2019.09.027. Epub 2019 Oct 9. Authors Nannan Lai
1 , Luyao Liu 2 , Li Lin 2 , Chaoqun Cui 1 , Ying Wang 2 , Qing Min 1 , Ermeng Xiong 1 , Wenjie
Wang 2 , Wenjing Ying 2 , Qinhua Zhou 2 , Jia Hou 2 , Jinqiao Sun 3 , Ji-Yang Wang 4 ,
Xiaochuan Wang 5 Affiliations 1 Department of Immunology, School of Basic Medical Sciences …
